Workflow
Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Tops Revenue Estimates
STROSutro Biopharma(STRO) ZACKS·2025-03-14 08:31

Sutro Biopharma, Inc. (STRO) came out with a quarterly loss of 0.89pershareversustheZacksConsensusEstimateofalossof0.89 per share versus the Zacks Consensus Estimate of a loss of 0.86. This compares to earnings of 0.42pershareayearago.Thesefiguresareadjustedfornonrecurringitems.Thisquarterlyreportrepresentsanearningssurpriseof3.490.42 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -3.49%. A quarter ago, it was expected that this company would post a loss of 0.74 per share when it actually produced a loss of $0.59, delivering a surprise of 20.27%.Over the last four quarters, the company ha ...